CSI Market
Sign In | Register

4d Molecular Therapeutics Inc (FDMT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access FDMT Annual Balance Sheets →
The table below presents a historical view of 4d Molecular Therapeutics Inc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent70.37
Marketable Securities, Current SH366.25
Cash & Short-term Investments436.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current17.01
Total Current Assets382.96
Equipment/Property/Plant Net35.82
Long-term investments69.30
Other Assets, Noncurrent4.54
Operating Lease Right Of Use Asset17.36
Total Assets492.62
Liabilities
Accounts Payable, Current AC12.52
Accrued Liabilities, Current AC25.43
Other Liabilities, Current9.72
Total Current Liabilities47.67
Long-term debt19.59
Total Long-term Debt19.59
Derivative Liability, Noncurrent DE0.38
Other liabilities, Noncurrent17.31
Contract With Customer Liability Current0.36
Contract With Customer Liability Noncurrent2.13
Operating Lease Liability Noncurrent15.05
Total Liabilities84.96
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,266.10
Retained Earnings / Accumulated Deficit-858.00
Accumulated Other Comprehensive Income-0.45
Other Equity-0.45
Common Stockholder's Equity407.66
Total Stockholder's Equity407.66
Liabilities & Stockholder's Equity492.62
4 historic quarters locked

Sign in to unlock the full 4d Molecular Therapeutics Inc balance sheet history.

Sign In Create Free Account

About 4D Molecular Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-349173

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.